ABSTRACT. Real-time PCR was optimized for the quantification of canine CD56 mRNA expression. This study was conducted to easily quantify canine CD56 expression and to identify its expression in normal tissues, peripheral blood mononuclear cells and activated lymphocytes in dogs. This assay revealed the highest level of CD56 mRNA expression in the normal canine brain, followed by the lung, kidney and liver. CD56 mRNA expression level in peripheral blood mononuclear cells was considerably lower; among activated lymphocytes in vitro, CD56 mRNA expression was increased.
Cluster of differentiation (CD) 56-a member of the immunoglobulin (IgG) superfamily-is the first cell adhesion molecule to have been identified and is also known as neural cell adhesion molecule [27] . By alternative RNA splicing and posttranslational modification, 3 different major CD56 protein isoforms (molecular weights: 180 kDa, 140 kDa, and 120 kDa) have been characterized [7, 9] . The structural characteristics of CD56 are related to its adhesion mechanisms [17, 22] , formation of the neural circuit, and development of the muscle. CD56 is expressed in various cells, particularly in neurons, myocytes, natural killer (NK) cells, and tumor cells [6] . Approximately 90% of the human NK cells express CD56 [10] . And NK cells play an important role in defense against viral infections, tumor remission, and graft rejection [4, 24] . Human NK cells are divided into several subsets according to the relative surface density of CD56 and CD16, which binds IgG complexes with a low affinity, and each function were analyzed [4, 19] .
Human CD56 is, therefore, considered to be a specific marker of NK cells and hence, one of the indicators of NK cells activation [26] .
In veterinary medicine, the sequence of canine CD56 has been reported to be considerably similar to that of human CD56 [2] , and feline CD56 has similar characteristics with human CD56 [25] . CD56 is suggested to be expressed in canine lymphocytes [21] ; however, the dynamics of CD56 in peripheral blood is not well understood. The CD56 expression level could be used for a mirror of NK activity if it is supposed to be specifically expressed in canine NK cells. Accordingly an assay system that easily detected CD56 expression may be of value to estimate NK activity in peripheral blood mononuclear cells (PBMCs).
The purpose of the present study is to establish the simple and easy polymerase chain reaction (PCR)-based method for detecting CD56 mRNA and to observe the changes in CD56 mRNA expression in lymphocytes by quantitative PCR after stimulating by two different methods.
This research was conducted according to the Guidelines for the Care and Use of Laboratory Animals of the Graduate School of Veterinary Medicine, Hokkaido University. Our experimental protocols were approved by the Institutional Animal Care and Use Committee of the Graduate School. The cerebral cortex, lung, liver, and kidney of a clinically normal 3-year-old male beagle were obtained after euthanizing it with sequential overdose injections of intravenous pentobarbital and saturated potassium chloride. The tissue samples were placed in a RNA-preserving solution (RNAlater; Ambion, Austin, TX, U.S.A.) overnight at 4°C, followed by storage at -80°C until RNA was extracted.
Peripheral blood samples from 5 clinically normal beagles (3 male and 2 female; age, 18-26 months; body weight, 12-14 kg) were heparinized (10 U/ml) and diluted twice with phosphate-buffered saline (PBS). PBMCs were collected by Ficoll-Paque density gradient centrifugation [3, 14] . And 1 × 10 6 PBMCs were separated into microtubes, and were stored at -20°C until further use for evaluation of CD56 mRNA expression. To obtain activated cultured lymphocytes, the complete medium [700 RU/ml interleukin (IL)-2 and 10% fetal bovine serum (Moregate Biotech, Bulimba, Australia)] comprising RPMI1640+9 (Nikken Biomedical Lab, Kyoto), RPMI1640 (GIBCO PBL, Gaithersburg, NY, U.S.A.), and inactivated fetal bovine serum in a ratio of 7:2:1, and a culture dish that was incubated for 24 hr at room temperature with a mixture of 25 µl of anti-CD3 antibody (1 mg/ml mouse anti-canine CD3; Serotec, Oxford, U.K.) in 5 ml physiological saline (final concentration, 5 µg/ml) were prepared. PBMCs were suspended to a final concentration of 1 × 10 7 cells/5 ml complete medium, and incubated in an anti-CD3 antibody coated dish at 37°C under 5% CO 2 . After 14 days, 1 × 10 6 activated cultured lymphocytes were collected and stored -20°C until further use. PBMCs were adjusted to a final concentration of 5× 10 6 cells/5 ml RPMI1640, and phytohemagglutinin (PHA; Invitrogen, Carlsbad, CA, U.S.A.) was added into the medium up to a final concentration of 10 µg/ml, and PBMCs suspension was incubated at 37°C under 5% CO 2 . After 4 days, 1 × 10 6 cells (PHA-stimulated lymphocytes) were collected and stored at -20°C until further use.
Total RNA was extracted from the tissue samples by the method of Chomczynski and Sacchi [5] . RNA was extracted from PBMCs, activated cultured lymphocytes and PHA-stimulated lymphocytes by using the RNeasy mini spin column (Qiagen, Les Ulis, France), according to the manufacturer's instructions. The absorbance was measured at a wavelength of 260 nm and the RNA was adjusted to a final concentration of 100 ng/µl. The RNA solution was stored at -80°C until further use. cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase (MMLV-RT) and random hexamer primers [15] . A reaction mixture (19 µl) containing 200 ng of RNA, 100 pmol of random hexamer primers, 4 µl of PCR buffer (5 ×), 20 µmol of deoxyribonucleoside 5 -triphosphates, 2 µl of 0.1 M dithiothreitol, and 6 µl of RNase-free water was pre-heated at 70°C for 5 min. Reverse transcription was allowed to occur at 37°C for 1 hr after adding 200 U of MMLV-RT. Further, the reaction mixture was heated to 94°C for 5 min in order to inactivate MMLV-RT. The cDNA solution was then stored at -20°C until use. Specific primers for CD56 were designed based on the previously reported highly conserved regions of human, murine, and canine CD56 cDNA sequences (GenBank accession no. AY860628). In order to quantitatively and qualitatively analyze the source RNA, the transcription levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were also measured. The following primer sequences were used for each gene-CD56: forward primer, 5'-TGC CGG CAT ATA CAA GTG TGT-3' and reverse primer, 5'-TGC CCC TGA TCT GCA GGT AGT-3'; and GAPDH: forward primer, 5'-GTG CTG AGT ATG TTG TGG AG-3' and reverse primer, 5'-AAG CAG TTG GTG GTG CAG GA-3'. We amplified cDNA by PCR using a reaction mixture containing 1.25 U of rTaq polymerase (Nippon gene, Toyama), 10 pmol of each primer, 5 µl of PCR buffer (10 ×), 40 mmol of deoxyribonucleoside 5-triphosphates, 2 µl of cDNA, and sterile distilled water to attain a final volume of 50 µl. The amplification comprised 35 cycles of denaturation at 94°C, annealing at 55°C, and extension at 72°C for 30 sec was each. Following this, the PCR products were analyzed by 2% agarose gel electrophoresis. Relative quantification was performed to determine the level of CD56 expression. We prepared a reaction mixture comprising 10 µl of water, 2.5 pmol of each primer, and 12.5 µl of SYBR Green PCR master mix (Applied Biosystems, Cheshire, U.K.), and 2 µl of cDNA was added as a template for the reaction. The amplification reaction was performed in 96-well optical reaction plates in an automated ABI 7300 real-time PCR system (Applied Biosystems, Tokyo). The reaction conditions were as follows: initial denaturation at 50°C for 2 min and at 95°C for 3 min, 50 cycles of denaturation at 95°C for 30 sec, annealing at 55°C for 30 sec, extension at 72°C for 1 min, and a final dissociation step (at 95°C for 15 sec, 60°C for 30 sec, and 95°C for 15 sec). The specificity of the amplification reaction was confirmed by examining the dissociation curve. A calibration curve was constructed using the CD56 PCR product in order to relatively quantify the obtained amplification product. The PCR products of CD56 were collected using Ultrafree-DA columns (Millipore, Bedford, MA, U.S.A.). The PCR products of CD56 were quantified and converted to copies/µl according to their respective molecular weights and Avogadro's number. The standard was serially diluted from 7 × 10 0 to 7 × 10 -6 copies/µl and amplified. The calibration curve was constructed based on the cycle that yielded a specific quantity of the amplification product (threshold cycle or Ct value) and a specific number of gene copies [13] . A calibration curve of GAPDH was also constructed. The gene expressions of each sample were calculated from the calibration curves.
All results are shown as the mean ± standard error. The alteration in CD56 gene expression was determined using the Wilcoxon signed-ranks test, and values of p<0.05 were considered significant.
To estimate the number of gene copies obtained, a calibration curve for CD56 cDNA amplifications was obtained as shown in Fig. 1 . A significant correlation was observed between the number of copies and the Ct value (r 2 =0.9916). CD56 mRNA expression in normal canine tissues was examined by PCR. The PCR products of cerebral cortex, lung, and kidney were visualized as clear bands on 2% agarose gel (data not shown). Real-time PCR was performed to examine the level of CD56 mRNA expression in normal canine tissues. The coefficient of variation (cv) obtained by CD56 complementary deoxyribonucleic acid was serially diluted from 7 × 10 0 to 7 × 10 -6 copies/µl and amplified. The calibration curves were obtained by plotting the threshold cycle (Ct) value and copy number of CD56. The correlation coefficient (r 2 ) value of the calibration curve was 0.9916, and significance of the correlation between the number of copies and the Ct values was confirmed.
subjecting each sample to real-time PCR 3 times and showed that the results were stable (cerebral cortex, 0.0005%; lung, 0.0071%; liver, 0.0085%; and kidney, 0.0066%). The CD56 expression level was adjusted per 1 × 10 6 GAPDH gene copies. Although CD56 mRNA expression was detected in all tissues that were examined in this study, it was highest in the cerebral cortex (Fig. 2) .
Relative quantification was performed to determine the level of CD56 mRNA expression in PBMCs, activated cultured lymphocytes and PHA-stimulated lymphocytes that were obtained from 3 normal dogs. CD56 mRNA expression was detected in all samples. Levels of CD56 mRNA expression were significantly higher in activated cultured lymphocytes (Fig. 3) and PHA-stimulated lymphocytes (Fig. 4) than that in non-stimulated PBMCs (p<0.01, p<0.05; respectively).
In the present study, real-time PCR was used to quantify canine CD56 mRNA expression in normal tissue samples, PBMCs and stimulated lymphocytes. The amount of total RNA needed for this technique was as small as 200 ng, which corresponded to the total volume of RNA extracted from 1.0 × 10 4 lymphocytes. The cv value was extremely low, and the stable measurement was possible.
In normal dogs, CD56 mRNA expression was highest in cerebral cortex and followed by the lung, kidney, and liver. It was previously suggested that CD56 played an important role in the development of the nervous system by participating in homogeneous adhesion between neuronal cells [12, 28] . CD56 expression in the lung tissue appeared to be related to the fact that CD56 contributes to bronchial function by supporting the interactions between bronchial epithelial cells and smooth muscle cells [12] . The kidney exhibited a low level of CD56 expression. It was previously reported that CD56 is closely related to the development of mesenchymal tissues, and CD56 expression gradually decreases as these tissues differentiate into epithelial tissues [11] .
In the present study, CD56 expression in the liver that had not been detected by PCR in a previous study [2] was detected by more sensitive quantitative PCR. Several reports state that extrathymic-T cells differentiate into CD56-positive T cells in the liver [18, 23] , and a similar phenomenon might have occurred in canine liver that led to the detection of slight CD56 expression. Higher CD56 mRNA expression was found in activated cultured lymphocytes that were activated by anti-CD3 antibody and IL-2, while lower CD56 mRNA expression could be still detected in PBMCs. CD56 expression increased in the PHA-stimulated lymphocytes, and the reason for its upregulation has been speculated as follows. PHA-identified as a T cell growth factor [20] -appeared to stimulate the growth of T cells among the cultured PBMCs, leading to the increased production of interferon-γ from them [2] . According to the results, interferon-γ might have upregulated CD56 mRNA expression. CD56 mRNA upregulation tended to occur in non-adherent PBMCs, which were obtained after separation of adherent cells through a nylon wool column (date not shown). These treatments are reported to select the population of NK cells [16] . Therefore, based on the results that canine CD56 mRNA expression was increased by these treatments, it has been predicated that canine NK cells, like human NK cells, also express CD56. In addition, this presumption is supported by the fact that a reported case of canine non-T, non-B lymphoid leukemia was determined to be of NK cell lineage by detecting specific canine CD56 mRNA expression [1] . Human NK cells play an important role in natural immunoresponse, and they are divided into 3 subsets (CD56   bright   /  CD16 neg , CD56 bright /CD16 dim , and CD56 dim /CD16 bright ), according to the relative surface density of CD56 and CD16, which binds IgG complexes with a low affinity. They have been designed for FcRIII and each function were analyzed [4, 19] . There is a possibility that CD56-positive and CD56-negative subpopulations may exist among canine NK cells. Because of the lack of a specific marker of canine NK cells, a further study would be necessary to correlate the number of CD56-positive cells with that of NK cells and to clarify the significance of CD56-positive cells.
In conclusion, we established a rapid and simple technique to quantify canine CD56 gene expression. By using the presently established technique, we confirmed a small proportion of CD56-positive cells was initially detected among the canine PBMCs, and the ratio of CD56-positive cells increased in activated lymphocytes by several stimulations.
